Novo Nordisk has appointed Maziar Mike Doustdar as CEO, replacing Lars Fruergaard, to address recent market challenges.

The U.K. will recognize a Palestinian state if there’s no cease-fire. Britain’s prime minister, Keir Starmer, announced ...

Though nerves abound for funders and founders in the industry, money continues to flow into startups, sometimes in ...

Under the Inflation Reduction Act, medications with the same active ingredient will be treated as the same drug for price ...

Swedish investment company EQT plans to take Fujitec, the Japanese maker of elevators and escalators, private through a $2.7 billion tender offer. The world's biggest coffee chain is moving away from ...

These are the top stocks that gained the attention of retail traders and investors throughout the day: ...

The pharmaceutical giant cut its guidance and said U.S. sales of Ozempic grew more slowly.

Danish drugmaker Novo Nordisk's stock was down nearly 20% in premarket trading Tuesday morning after the company cut its ...

Shares of Hims & Hers, which has clashed with Novo Nordisk over its sales of compounded glucagon-like peptide inhibitors, rose slightly in the wake of the report, and have more than doubled in value ...

One of the more popular stocks in the pharmaceutical sector of late got the cold shoulder from investors on Tuesday. Eli Lilly ( LLY -5.50%) closed today's trading session down by almost 6% in value, ...

Novo now expects 2025 sales growth of 8%-14% in local currencies, down from its previous 13-21% range. It also lowered its ...

Import duties on Chinese goods could surge to about 80% if the pause expires on Aug. 12. Plus: UnitedHealth Group said its ...